Atlas Trials

Calorie Restriction With or Without Metformin in Triple Negative Breast Cancer

Clinical trial NCT04248998 · UNKNOWN

Trial details

NCT number
NCT04248998
Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Triple-negative Breast Cancer
Start date
2020-05-05
Primary completion
2024-05-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.